# A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity

> **NCT06352437** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 125 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 3034701
- **DRUG:** Placebo matching BI 3034701

## Key facts

- **NCT ID:** NCT06352437
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-10
- **Primary completion:** 2025-10-07
- **Final completion:** 2025-10-07
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06352437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06352437, "A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06352437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*